The Barchart Chart of the Day belongs to the oncology stock NovoCure (NVCR).
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.
(Click on image to enlarge)
Barchart technical indicators:
- 100% technical buy signals
- 129.90+ Weighted Alpha
- 100.88% gain in the last year
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 4 new highs and up 10.12% in the last month
- Relative Strength Index 71.26%
- Technical support level at 38.13
- Recently traded at 39.99 with a 50 day moving average of 34.50
Fundamental factors:
- Market Cap $3.60 billion
- Revenue expected to grow 42.00% this year and another 50.00% next year
- Earnings estimated to increase 5.70% this year, an additional 124.20% next year and continue to compound at an annual rate of 60.00% for the next 5 years
- Wall Street analysts issued 2 strong buy, 3 buy and 1 hold recommendation on the stock
